Skip to main content
Top
Published in: Osteoporosis International 4/2009

01-04-2009 | Original Article

Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women’s Health Initiative

Authors: Z. Chen, M. Maricic, A. K. Aragaki, C. Mouton, L. Arendell, A. M. Lopez, T. Bassford, R. T. Chlebowski

Published in: Osteoporosis International | Issue 4/2009

Login to get access

Abstract

Summary

Risk for falls and fractures increases after breast cancer or other cancer diagnosis in postmenopausal women. Factors other than falls may be the major causes for the increased fracture risk.

Introduction

Cancer treatment and prognosis may have detrimental effects on bone health. However, there is a lack of prospective investigations on fracture risk among incident cancer cases.

Methods

In this study, postmenopausal women (N = 146,959) from the Women’s Health Initiative prospective cohort, who had no cancer history at baseline, were followed for up to 9 years and classified into no cancer, incident breast cancer (BC) and incident other cancer (OC) groups. The main outcomes measured were incident fractures and falls before and after cancer diagnosis. Hazards ratios (HR) and 95% confidence intervals (CI) were computed from Cox proportional hazards model.

Results

While hip fracture risk before a cancer diagnosis was similar between the no cancer and cancer groups, hip fracture risk was significantly higher after BC diagnosis (HR = 1.55, CI = 1.13–2.11) and the elevated risk was even more notable after OC diagnosis (HR = 2.09, CI = 1.65–2.65). Risk of falls also increased after BC (HR = 1.15, CI = 1.06–1.25) or OC diagnosis (HR = 1.27, CI = 1.18–1.36), but could not fully explain the elevated hip fracture risk. Incident clinical vertebral and total fractures were also significantly increased after OC diagnosis (p < 0.05).

Conclusions

Postmenopausal women have significantly elevated risks for falls and fractures after a cancer diagnosis. The causes for this increased risk remained to be investigated.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRef Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRef
2.
go back to reference Cauley JA, Lucas FL, Kuller LH et al (1996) Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. Jama 276:1404–1408CrossRef Cauley JA, Lucas FL, Kuller LH et al (1996) Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. Jama 276:1404–1408CrossRef
3.
go back to reference Newcomb PA, Trentham-Dietz A, Egan KM et al (2001) Fracture history and risk of breast and endometrial cancer. Am J Epidemiol 153:1071–1078CrossRef Newcomb PA, Trentham-Dietz A, Egan KM et al (2001) Fracture history and risk of breast and endometrial cancer. Am J Epidemiol 153:1071–1078CrossRef
4.
go back to reference Chen Z, Maricic M, Pettinger M et al (2005) Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer 104:1520–1530CrossRef Chen Z, Maricic M, Pettinger M et al (2005) Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer 104:1520–1530CrossRef
5.
go back to reference Friedlaender GE, Tross RB, Doganis AC et al (1984) Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am 66:602–607 Friedlaender GE, Tross RB, Doganis AC et al (1984) Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am 66:602–607
6.
go back to reference May KP, West SG, McDermott MT et al (1994) The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 37:201–206CrossRef May KP, West SG, McDermott MT et al (1994) The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 37:201–206CrossRef
7.
go back to reference Twiss JJ, Waltman N, Ott CD et al (2001) Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract 13:276–284 Twiss JJ, Waltman N, Ott CD et al (2001) Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract 13:276–284
8.
go back to reference Chen Z, Maricic M, Bassford TL et al (2005) Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study. Arch Intern Med 165:552–558CrossRef Chen Z, Maricic M, Bassford TL et al (2005) Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study. Arch Intern Med 165:552–558CrossRef
9.
go back to reference Michaud LB, Goodin S (2006) Cancer-treatment-induced bone loss, part 1. Am J Health Syst Pharm 63:419–430CrossRef Michaud LB, Goodin S (2006) Cancer-treatment-induced bone loss, part 1. Am J Health Syst Pharm 63:419–430CrossRef
10.
go back to reference Rivara FP, Grossman DC, Cummings P (1997) Injury prevention. Second of two parts. N Engl J Med 337:613–618CrossRef Rivara FP, Grossman DC, Cummings P (1997) Injury prevention. Second of two parts. N Engl J Med 337:613–618CrossRef
11.
go back to reference WHI (1998) Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group. Control Clin Trials 19:61–109CrossRef WHI (1998) Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group. Control Clin Trials 19:61–109CrossRef
12.
go back to reference Langer RD, White E, Lewis CE et al (2003) The Women’s Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107–121CrossRef Langer RD, White E, Lewis CE et al (2003) The Women’s Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107–121CrossRef
13.
go back to reference Chen Z, Kooperberg C, Pettinger MB et al (2004) Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women’s Health Initiative observational study and clinical trials. Menopause 11:264–274CrossRef Chen Z, Kooperberg C, Pettinger MB et al (2004) Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women’s Health Initiative observational study and clinical trials. Menopause 11:264–274CrossRef
14.
go back to reference Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. New York, Wiley Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. New York, Wiley
15.
go back to reference Cauley JA, Wu L, Wampler NS et al (2007) Clinical risk factors for fractures in multiethnic women: The Women’s Health Initiative. J Bone Miner Res 22:1816–1826CrossRef Cauley JA, Wu L, Wampler NS et al (2007) Clinical risk factors for fractures in multiethnic women: The Women’s Health Initiative. J Bone Miner Res 22:1816–1826CrossRef
16.
go back to reference Prentice RL (1989) Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8:431–440CrossRef Prentice RL (1989) Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8:431–440CrossRef
17.
go back to reference Delmas PD, Fontana A (1998) Bone loss induced by cancer treatment and its management. Eur J Cancer 34:260–262CrossRef Delmas PD, Fontana A (1998) Bone loss induced by cancer treatment and its management. Eur J Cancer 34:260–262CrossRef
18.
go back to reference Adami HO, Zack M, Kressner U et al (1990) Hip fractures in women with breast cancer. Am J Epidemiol 132:877–883 Adami HO, Zack M, Kressner U et al (1990) Hip fractures in women with breast cancer. Am J Epidemiol 132:877–883
19.
go back to reference Kanis JA, McCloskey EV, Powles T et al (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179–1181CrossRef Kanis JA, McCloskey EV, Powles T et al (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179–1181CrossRef
20.
go back to reference Lamont EB, Lauderdale DS (2003) Low risk of hip fracture among elderly breast cancer survivors. Ann Epidemiol 13:698–703CrossRef Lamont EB, Lauderdale DS (2003) Low risk of hip fracture among elderly breast cancer survivors. Ann Epidemiol 13:698–703CrossRef
21.
go back to reference Chang J, Powles TJ, Ashley SE et al (1996) The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. Ann Oncol 7:671–675 Chang J, Powles TJ, Ashley SE et al (1996) The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. Ann Oncol 7:671–675
22.
go back to reference Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388CrossRef Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388CrossRef
23.
go back to reference Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319:1701–1707 Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319:1701–1707
24.
go back to reference Nevitt MC, Cummings SR, Hudes ES (1991) Risk factors for injurious falls: a prospective study. J Gerontol 46:M164–170 Nevitt MC, Cummings SR, Hudes ES (1991) Risk factors for injurious falls: a prospective study. J Gerontol 46:M164–170
25.
go back to reference Greenspan SL, Bhattacharya RK, Sereika SM et al (2007) Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 92:131–136CrossRef Greenspan SL, Bhattacharya RK, Sereika SM et al (2007) Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 92:131–136CrossRef
Metadata
Title
Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women’s Health Initiative
Authors
Z. Chen
M. Maricic
A. K. Aragaki
C. Mouton
L. Arendell
A. M. Lopez
T. Bassford
R. T. Chlebowski
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 4/2009
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-008-0721-0

Other articles of this Issue 4/2009

Osteoporosis International 4/2009 Go to the issue